Dietary Supplements Revenue Growth
Dietary supplements revenue grew 8.4% to $11.2 million, primarily driven by the continued growth of the e-commerce channel. Biote expects mid-teens revenue growth for the dietary supplements business for the fiscal year 2025.
Gross Profit Margin Improvement
Gross profit margin increased by 150 basis points to 71.8%, reflecting cost savings from the vertical integration of the 503(B) manufacturing facility and effective cost management.
Increased Cash Flow from Operations
Third quarter cash flow from operations increased by $14.1 million to $27.6 million.
Share Repurchase Program
Biote repurchased approximately 1 million shares of Class A common stock at an average price of $3.28 per share under the $20 million common share repurchase program.
Successful Marketing Event
Biote hosted the annual Sun, Sea and Biote marketing event, attracting over 800 attendees and featuring notable speakers, reinforcing its leadership in hormone optimization.